Meeting
2012 ASCO Annual Meeting
A multi-institution study of the accuracy of BRCAPRO in predicting BRCA1/BRCA2 mutations in women with ovarian cancer.
Authors
Molly S Daniels
University of Texas M. D. Anderson Cancer Center, Houston, TX
Molly S Daniels , Sheri Babb , Robin King , Diana Urbauer , Christopher I. Amos , Amanda C. Brandt , Adam Buchanan , David Gardner Mutch , Karen H. Lu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Genetics
Citation
J Clin Oncol 30, 2012 (suppl; abstr 1520)
DOI
10.1200/jco.2012.30.15_suppl.1520
Abstract #
1520
Poster Bd #
9
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199.
First Author: Phuong L. Mai
Poster
2016 ASCO Annual Meeting
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
First Author: Philipp Harter
Poster
2013 ASCO Annual Meeting
The first 10 years experience with genetic testing (GT) for BRCA1/2 mutations in a publicly funded program at a tertiary care teaching hospital in Ontario, Canada.
First Author: Sherry Athena Doroja Ruste
Poster
2013 ASCO Annual Meeting
Prevalence and differentiation of hereditary breast and ovarian cancer in Japan.
First Author: Seigo Nakamura